Trial Profile
A Clinical Study to Evaluate Remdisivir in Combination with Old Rheumatoid Arthritis Drug Chloroquine in China
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2020
Price :
$35
*
At a glance
- Drugs Chloroquine (Primary) ; Remdesivir (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 11 Mar 2020 New trial record